W Phipatanakul1, P A Eggleston, E C Wright, R A Wood. 1. Department of Pediatrics, Division of Allergy and Immunology, Children's Hospital, Harvard University School of Medicine, Boston, MA, USA.
Abstract
BACKGROUND: Although mouse allergen is known to cause occupational asthma in laboratory workers, its potential significance in home environments has never been studied. OBJECTIVE: This study was designed to define the prevalence of mouse sensitivity and its relationship to mouse allergen exposure and disease activity in inner-city children with asthma. METHODS: A subset of 499 subjects from the National Cooperative Inner-City Asthma Study had dust samples adequate for mouse allergen analysis, as well as valid puncture skin test (PST) results. Data were analyzed to relate mouse allergen exposure and other risk factors to mouse sensitization and asthma morbidity. RESULTS: Eighty-nine (18%) of the 499 children had a positive mouse skin test response. Children whose homes had mouse allergen levels above the median (1.60 microg/g) in the kitchen had a significantly higher rate of mouse sensitization (23% vs 11%, P =. 007). Atopy was also significantly related to mouse sensitization, with 40% of those with more than 4 positive PST responses having mouse sensitivity compared with 4% of those with no other positive PST responses (P <.0001). When atopy and exposure were considered together, 53% of those with more than 4 positive PST responses and allergen levels above the median had a positive PST response to mouse allergen compared with 22% of those with more than 4 positive PST responses and allergen levels below the median (P <.0001). The relationship among mouse allergen exposure, sensitization, and any measures of asthma morbidity was not statistically significant. CONCLUSIONS: Mouse allergen may be an important indoor allergen in inner-city children with asthma, with exposure and atopy contributing to mouse sensitization.
BACKGROUND: Although mouse allergen is known to cause occupational asthma in laboratory workers, its potential significance in home environments has never been studied. OBJECTIVE: This study was designed to define the prevalence of mouse sensitivity and its relationship to mouse allergen exposure and disease activity in inner-city children with asthma. METHODS: A subset of 499 subjects from the National Cooperative Inner-City Asthma Study had dust samples adequate for mouse allergen analysis, as well as valid puncture skin test (PST) results. Data were analyzed to relate mouse allergen exposure and other risk factors to mouse sensitization and asthma morbidity. RESULTS: Eighty-nine (18%) of the 499 children had a positive mouse skin test response. Children whose homes had mouse allergen levels above the median (1.60 microg/g) in the kitchen had a significantly higher rate of mouse sensitization (23% vs 11%, P =. 007). Atopy was also significantly related to mouse sensitization, with 40% of those with more than 4 positive PST responses having mouse sensitivity compared with 4% of those with no other positive PST responses (P <.0001). When atopy and exposure were considered together, 53% of those with more than 4 positive PST responses and allergen levels above the median had a positive PST response to mouse allergen compared with 22% of those with more than 4 positive PST responses and allergen levels below the median (P <.0001). The relationship among mouse allergen exposure, sensitization, and any measures of asthma morbidity was not statistically significant. CONCLUSIONS:Mouse allergen may be an important indoor allergen in inner-city children with asthma, with exposure and atopy contributing to mouse sensitization.
Authors: Lindsay Rosenfeld; Ginger L Chew; Rima Rudd; Karen Emmons; Luis Acosta; Matt Perzanowski; Dolores Acevedo-García Journal: J Urban Health Date: 2011-02 Impact factor: 3.671
Authors: Robin S Everhart; Sheryl Kopel; Elizabeth L McQuaid; Leslie Salcedo; Daniel York; Christina Potter; Daphne Koinis-Mitchell Journal: Pediatr Allergy Immunol Pulmonol Date: 2011-09 Impact factor: 1.349
Authors: Junenette L Peters; Jonathan I Levy; Christine A Rogers; Harriet A Burge; John D Spengler Journal: J Urban Health Date: 2007-03 Impact factor: 3.671
Authors: Wanda Phipatanakul; Augusto A Litonjua; Thomas A E Platts-Mills; Lisa M Naccara; Juan C Celedón; Hassen Abdulkerim; Elaine B Hoffman; Diane R Gold Journal: J Allergy Clin Immunol Date: 2007-06-25 Impact factor: 10.793
Authors: Päivi M Salo; Samuel J Arbes; Patrick W Crockett; Peter S Thorne; Richard D Cohn; Darryl C Zeldin Journal: J Allergy Clin Immunol Date: 2008-02-06 Impact factor: 10.793
Authors: Jill Berg; Rob McConnell; Joel Milam; Judith Galvan; Jenny Kotlerman; Peter Thorne; Craig Jones; Ronald Ferdman; Peyton Eggleston; Cynthia Rand; Mary Ann Lewis; John Peters; Jean Richardson Journal: J Urban Health Date: 2007-11-15 Impact factor: 3.671
Authors: James R Roberts; Catherine J Karr; Lisa de Ybarrondo; Leyla E McCurdy; Katherine D Freeland; Thomas C Hulsey; Joel Forman Journal: Clin Pediatr (Phila) Date: 2013-03-28 Impact factor: 1.168